The goal of follicular lymphoma treatment is to put your disease into remission. That means your symptoms, and signs doctors look for on scans, diminish or disappear. You can stay in remission for ...

There are two types of lymphomas: Hodgkin's and non-Hodgkin's, based on the kind of white blood cell they affect. Follicular lymphoma is a non-Hodgkin's lymphoma that affects white blood cells called ...

Current NCCN Guidelines recommend molecular testing for patients with follicular lymphoma, which has improved diagnostic accuracy and can assist in selecting the appropriate treatment in certain cases ...

Follicular lymphoma is graded 1 to 3 based on how many large B cells (centroblasts) appear under a microscope, which signals how fast it may grow. Grade 1 and 2 follicular lymphoma are usually slow ...

For some people, treating follicular lymphoma involves active surveillance until severe symptoms develop. For others, chemoimmunotherapy, radiation therapy, or targeted treatments may be necessary.

The shift toward dual-targeting bispecifics and the imminent arrival of highly efficacious triple combinations could shift the follicular lymphoma treatment space. The future treatment landscape for ...

Follicular lymphoma -- typically a slow-growing or indolent form of non-Hodgkin lymphoma that arises from B lymphocytes -- accounts for 20% to 30% of all non-Hodgkin lymphoma cases. The indolent ...

Please provide your email address to receive an email when new articles are posted on . Follicular lymphoma is among the least common types of non-Hodgkin lymphoma, but the nature of the disease has ...

The TERZO study evaluates Copiktra for relapsed or refractory nodal T-follicular helper cell lymphoma, lacking a standard treatment. The trial compares Copiktra with Gemzar or Bendeka, focusing on ...

Response-Adapted Postinduction Strategy in Patients With Advanced-Stage Follicular Lymphoma: The FOLL12 Study The following represents disclosure information provided by authors of this manuscript.